Global Mesalamine Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Global Mesalamine Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

  • SKU :
    SAC3052992
  • Published Date :
    May 31, 2024
  • Number of Pages :
    300

Product Description

The Mesalamine market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.

Considering the influence of COVID-19 on the global Mesalamine market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Mesalamine Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Mesalamine market are:
Teva
Cipla
Pfizer
Takeda
Synmosa Biopharma Corporation
Janssen (Johnson & Johnson)
Abbvie
Ferring
Sandoz Mesalamine
Dr Falk Pharma
Nogra Pharma
Shanghai Sine Promod Pharmaceutical
Boehringer Ingelheim
Allergan
AstraZeneca
Lunan Better Pharmaceutical
Salix Pharmaceuticals
Tillotts Pharma
Mylan
Cosmo Pharmaceuticals
Chiesi Farmaceutici

Most important types of Mesalamine products covered in this report are:
Capsule
Tablets

Most widely used downstream fields of Mesalamine market covered in this report are:
Adult
Children

Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.





Table of Content

Table of Content

1 Mesalamine Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Mesalamine
1.3 Mesalamine Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Mesalamine Revenue and Growth Rate from 2019-2031
1.4 Market Segmentation
1.4.1 Types of Mesalamine
1.4.2 Applications of Mesalamine
1.4.3 Research Regions
1.5 Market Dynamics
1.5.1 Mesalamine Industry Trends
1.5.2 Mesalamine Drivers
1.5.3 Mesalamine Market Challenges
1.5.4 Mesalamine Market Restraints
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
1.7 Mergers & Acquisitions, Expansion Plans
1.8 Mesalamine Industry Development Trends under COVID-19 Outbreak
1.8.1 Global COVID-19 Status Overview
1.8.2 Influence of COVID-19 Outbreak on Mesalamine Industry Development

2 Industry Chain Analysis
2.1 Upstream Raw Material Supply and Demand Analysis
2.1.1 Global Mesalamine Major Upstream Raw Material and Suppliers
2.1.2 Raw Material Source Analysis
2.2 Major Players of Mesalamine
2.2.1 Major Players Manufacturing Base of Mesalamine in 2020
2.2.2 Major Players Market Distribution in 2020
2.3 Mesalamine Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Mesalamine
2.3.3 Labor Cost of Mesalamine
2.4 Market Channel Analysis of Mesalamine
2.5 Major Down Stream Customers by Application

3 Global Mesalamine Market, by Type
3.1 Global Mesalamine Revenue and Market Share by Type (2019-2023)
3.2 Global Mesalamine Production and Market Share by Type (2019-2023)
3.3 Global Mesalamine Revenue and Growth Rate by Type (2019-2023)
3.3.1 Global Mesalamine Revenue and Growth Rate of Capsule
3.3.2 Global Mesalamine Revenue and Growth Rate of Tablets
3.4 Global Mesalamine Price Analysis by Type (2019-2023)
3.4.1 Explanation of Different Type Product Price Trends

4 Mesalamine Market, by Application
4.1 Downstream Market Overview
4.2 Global Mesalamine Consumption and Market Share by Application (2019-2023)
4.3 Global Mesalamine Consumption and Growth Rate by Application (2019-2023)
4.3.1 Global Mesalamine Consumption and Growth Rate of Adult (2019-2023)
4.3.2 Global Mesalamine Consumption and Growth Rate of Children (2019-2023)

5 Global Mesalamine Consumption, Revenue ($) by Region (2019-2023)
5.1 Global Mesalamine Revenue and Market Share by Region (2019-2023)
5.2 Global Mesalamine Consumption and Market Share by Region (2019-2023)
5.3 Global Mesalamine Consumption, Revenue, Price and Gross Margin (2019-2023)
5.4 North America Mesalamine Consumption, Revenue, Price and Gross Margin (2019-2023)
5.4.1 North America Mesalamine Market Under COVID-19
5.4.2 North America Mesalamine SWOT Analysis
5.5 Europe Mesalamine Consumption, Revenue, Price and Gross Margin (2019-2023)
5.5.1 Europe Mesalamine Market Under COVID-19
5.5.2 Europe Mesalamine SWOT Analysis
5.6 China Mesalamine Consumption, Revenue, Price and Gross Margin (2019-2023)
5.6.1 China Mesalamine Market Under COVID-19
5.6.2 China Mesalamine SWOT Analysis
5.7 Japan Mesalamine Consumption, Revenue, Price and Gross Margin (2019-2023)
5.7.1 Japan Mesalamine Market Under COVID-19
5.7.2 Japan Mesalamine SWOT Analysis
5.8 Middle East and Africa Mesalamine Consumption, Revenue, Price and Gross Margin (2019-2023)
5.8.1 Middle East and Africa Mesalamine Market Under COVID-19
5.8.2 Middle East and Africa Mesalamine SWOT Analysis
5.9 India Mesalamine Consumption, Revenue, Price and Gross Margin (2019-2023)
5.9.1 India Mesalamine Market Under COVID-19
5.9.2 India Mesalamine SWOT Analysis
5.10 South America Mesalamine Consumption, Revenue, Price and Gross Margin (2019-2023)
5.10.1 South America Mesalamine Market Under COVID-19
5.10.2 South America Mesalamine SWOT Analysis
5.11 South Korea Mesalamine Consumption, Revenue, Price and Gross Margin (2019-2023)
5.11.1 South Korea Mesalamine Market Under COVID-19
5.11.2 South Korea Mesalamine SWOT Analysis
5.12 Southeast Asia Mesalamine Consumption, Revenue, Price and Gross Margin (2019-2023)
5.12.1 Southeast Asia Mesalamine Market Under COVID-19
5.12.2 Southeast Asia Mesalamine SWOT Analysis

6 Global Mesalamine Production by Top Regions (2019-2023)
6.1 Global Mesalamine Production by Top Regions (2019-2023)
6.2 North America Mesalamine Production and Growth Rate
6.3 Europe Mesalamine Production and Growth Rate
6.4 China Mesalamine Production and Growth Rate
6.5 Japan Mesalamine Production and Growth Rate
6.6 India Mesalamine Production and Growth Rate

7 Global Mesalamine Consumption by Regions (2019-2023)
7.1 Global Mesalamine Consumption by Regions (2019-2023)
7.2 North America Mesalamine Consumption and Growth Rate
7.3 Europe Mesalamine Consumption and Growth Rate
7.4 China Mesalamine Consumption and Growth Rate
7.5 Japan Mesalamine Consumption and Growth Rate
7.6 Middle East & Africa Mesalamine Consumption and Growth Rate
7.7 India Mesalamine Consumption and Growth Rate
7.8 South America Mesalamine Consumption and Growth Rate
7.9 South Korea Mesalamine Consumption and Growth Rate
7.10 Southeast Asia Mesalamine Consumption and Growth Rate

8 Competitive Landscape
8.1 Competitive Profile
8.2 Teva Market Performance Analysis
8.2.1 Company Profiles
8.2.2 Mesalamine Product Profiles, Application and Specification
8.2.3 Teva Sales, Revenue, Price, Gross Margin 2019-2023
8.2.4 Company Recent Development
8.2.5 Strategies for Company to Deal with the Impact of COVID-19
8.3 Cipla Market Performance Analysis
8.3.1 Company Profiles
8.3.2 Mesalamine Product Profiles, Application and Specification
8.3.3 Cipla Sales, Revenue, Price, Gross Margin 2019-2023
8.3.4 Company Recent Development
8.3.5 Strategies for Company to Deal with the Impact of COVID-19
8.4 Pfizer Market Performance Analysis
8.4.1 Company Profiles
8.4.2 Mesalamine Product Profiles, Application and Specification
8.4.3 Pfizer Sales, Revenue, Price, Gross Margin 2019-2023
8.4.4 Company Recent Development
8.4.5 Strategies for Company to Deal with the Impact of COVID-19
8.5 Takeda Market Performance Analysis
8.5.1 Company Profiles
8.5.2 Mesalamine Product Profiles, Application and Specification
8.5.3 Takeda Sales, Revenue, Price, Gross Margin 2019-2023
8.5.4 Company Recent Development
8.5.5 Strategies for Company to Deal with the Impact of COVID-19
8.6 Synmosa Biopharma Corporation Market Performance Analysis
8.6.1 Company Profiles
8.6.2 Mesalamine Product Profiles, Application and Specification
8.6.3 Synmosa Biopharma Corporation Sales, Revenue, Price, Gross Margin 2019-2023
8.6.4 Company Recent Development
8.6.5 Strategies for Company to Deal with the Impact of COVID-19
8.7 Janssen (Johnson & Johnson) Market Performance Analysis
8.7.1 Company Profiles
8.7.2 Mesalamine Product Profiles, Application and Specification
8.7.3 Janssen (Johnson & Johnson) Sales, Revenue, Price, Gross Margin 2019-2023
8.7.4 Company Recent Development
8.7.5 Strategies for Company to Deal with the Impact of COVID-19
8.8 Abbvie Market Performance Analysis
8.8.1 Company Profiles
8.8.2 Mesalamine Product Profiles, Application and Specification
8.8.3 Abbvie Sales, Revenue, Price, Gross Margin 2019-2023
8.8.4 Company Recent Development
8.8.5 Strategies for Company to Deal with the Impact of COVID-19
8.9 Ferring Market Performance Analysis
8.9.1 Company Profiles
8.9.2 Mesalamine Product Profiles, Application and Specification
8.9.3 Ferring Sales, Revenue, Price, Gross Margin 2019-2023
8.9.4 Company Recent Development
8.9.5 Strategies for Company to Deal with the Impact of COVID-19
8.10 Sandoz Mesalamine Market Performance Analysis
8.10.1 Company Profiles
8.10.2 Mesalamine Product Profiles, Application and Specification
8.10.3 Sandoz Mesalamine Sales, Revenue, Price, Gross Margin 2019-2023
8.10.4 Company Recent Development
8.10.5 Strategies for Company to Deal with the Impact of COVID-19
8.11 Dr Falk Pharma Market Performance Analysis
8.11.1 Company Profiles
8.11.2 Mesalamine Product Profiles, Application and Specification
8.11.3 Dr Falk Pharma Sales, Revenue, Price, Gross Margin 2019-2023
8.11.4 Company Recent Development
8.11.5 Strategies for Company to Deal with the Impact of COVID-19
8.12 Nogra Pharma Market Performance Analysis
8.12.1 Company Profiles
8.12.2 Mesalamine Product Profiles, Application and Specification
8.12.3 Nogra Pharma Sales, Revenue, Price, Gross Margin 2019-2023
8.12.4 Company Recent Development
8.12.5 Strategies for Company to Deal with the Impact of COVID-19
8.13 Shanghai Sine Promod Pharmaceutical Market Performance Analysis
8.13.1 Company Profiles
8.13.2 Mesalamine Product Profiles, Application and Specification
8.13.3 Shanghai Sine Promod Pharmaceutical Sales, Revenue, Price, Gross Margin 2019-2023
8.13.4 Company Recent Development
8.13.5 Strategies for Company to Deal with the Impact of COVID-19
8.14 Boehringer Ingelheim Market Performance Analysis
8.14.1 Company Profiles
8.14.2 Mesalamine Product Profiles, Application and Specification
8.14.3 Boehringer Ingelheim Sales, Revenue, Price, Gross Margin 2019-2023
8.14.4 Company Recent Development
8.14.5 Strategies for Company to Deal with the Impact of COVID-19
8.15 Allergan Market Performance Analysis
8.15.1 Company Profiles
8.15.2 Mesalamine Product Profiles, Application and Specification
8.15.3 Allergan Sales, Revenue, Price, Gross Margin 2019-2023
8.15.4 Company Recent Development
8.15.5 Strategies for Company to Deal with the Impact of COVID-19
8.16 AstraZeneca Market Performance Analysis
8.16.1 Company Profiles
8.16.2 Mesalamine Product Profiles, Application and Specification
8.16.3 AstraZeneca Sales, Revenue, Price, Gross Margin 2019-2023
8.16.4 Company Recent Development
8.16.5 Strategies for Company to Deal with the Impact of COVID-19
8.17 Lunan Better Pharmaceutical Market Performance Analysis
8.17.1 Company Profiles
8.17.2 Mesalamine Product Profiles, Application and Specification
8.17.3 Lunan Better Pharmaceutical Sales, Revenue, Price, Gross Margin 2019-2023
8.17.4 Company Recent Development
8.17.5 Strategies for Company to Deal with the Impact of COVID-19
8.18 Salix Pharmaceuticals Market Performance Analysis
8.18.1 Company Profiles
8.18.2 Mesalamine Product Profiles, Application and Specification
8.18.3 Salix Pharmaceuticals Sales, Revenue, Price, Gross Margin 2019-2023
8.18.4 Company Recent Development
8.18.5 Strategies for Company to Deal with the Impact of COVID-19
8.19 Tillotts Pharma Market Performance Analysis
8.19.1 Company Profiles
8.19.2 Mesalamine Product Profiles, Application and Specification
8.19.3 Tillotts Pharma Sales, Revenue, Price, Gross Margin 2019-2023
8.19.4 Company Recent Development
8.19.5 Strategies for Company to Deal with the Impact of COVID-19
8.20 Mylan Market Performance Analysis
8.20.1 Company Profiles
8.20.2 Mesalamine Product Profiles, Application and Specification
8.20.3 Mylan Sales, Revenue, Price, Gross Margin 2019-2023
8.20.4 Company Recent Development
8.20.5 Strategies for Company to Deal with the Impact of COVID-19
8.21 Cosmo Pharmaceuticals Market Performance Analysis
8.21.1 Company Profiles
8.21.2 Mesalamine Product Profiles, Application and Specification
8.21.3 Cosmo Pharmaceuticals Sales, Revenue, Price, Gross Margin 2019-2023
8.21.4 Company Recent Development
8.21.5 Strategies for Company to Deal with the Impact of COVID-19
8.22 Chiesi Farmaceutici Market Performance Analysis
8.22.1 Company Profiles
8.22.2 Mesalamine Product Profiles, Application and Specification
8.22.3 Chiesi Farmaceutici Sales, Revenue, Price, Gross Margin 2019-2023
8.22.4 Company Recent Development
8.22.5 Strategies for Company to Deal with the Impact of COVID-19

9 Global Mesalamine Market Analysis and Forecast by Type and Application
9.1 Global Mesalamine Market Revenue & Volume Forecast, by Type (2021-2026)
9.1.1 Capsule Market Revenue and Volume Forecast (2021-2026)
9.1.2 Tablets Market Revenue and Volume Forecast (2021-2026)
9.2 Global Mesalamine Market Revenue & Volume Forecast, by Application (2021-2026)
9.2.1 Adult Market Revenue and Volume Forecast (2021-2026)
9.2.2 Children Market Revenue and Volume Forecast (2021-2026)

10 Mesalamine Market Supply and Demand Forecast by Region
10.1 North America Market Supply and Demand Forecast (2021-2026)
10.2 Europe Market Supply and Demand Forecast (2021-2026)
10.3 China Market Supply and Demand Forecast (2021-2026)
10.4 Japan Market Supply and Demand Forecast (2021-2026)
10.5 Middle East and Africa Market Supply and Demand Forecast (2021-2026)
10.6 India Market Supply and Demand Forecast (2021-2026)
10.7 South America Market Supply and Demand Forecast (2021-2026)
10.8 South Korea Market Supply and Demand Forecast (2021-2026)
10.9 Southeast Asia Market Supply and Demand Forecast (2021-2026)
10.10 Explanation of Market Size Trends by Region
10.11 Mesalamine Market Trends Analysis

11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment

12 Expert Interview Record
13 Research Finding and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Data Source
 

Search results for Biotechnology Industry